Comment: bioavailability and safety of two ceftriaxone formulations--exposure to lidocaine questioned.
Seay
R E
RE
D000328:Adult; D000779:Anesthetics, Local / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use; D001682:Biological Availability; D002443:Ceftriaxone / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use; D002511:Cephalosporins / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use; D002648:Child; D004338:Drug Combinations; D006801:Humans; D008012:Lidocaine / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use
D000779:Anesthetics, Local; D002511:Cephalosporins; D004338:Drug Combinations; D002443:Ceftriaxone; D008012:Lidocaine